Wullimann D

Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a two-year follow-up of the prospective clinical trial COVAXID.

Chen P, Bergman P, Blennow O, ..., Aleman S, Ljunggren HG

EBioMedicine 109 (-) 105385 [2024-11-00; online 2024-10-11]

Systemic and mucosal adaptive immunity to SARS-CoV-2 during the Omicron wave in patients with chronic lymphocytic leukemia

Ingelman-Sundberg H, Blixt L, Wullimann D, ..., Buggert M, Österborg A

- - (-) - [2023-01-10; online 2023-01-10]

Hybrid immunity in immunocompromised patients with CLL after SARS-CoV-2 infection followed by booster mRNA vaccination.

Blixt L, Gao Y, Wullimann D, ..., Hansson L, Österborg A

Blood 140 (22) 2403-2407 [2022-12-01; online 2022-09-24]